デフォルト表紙
市場調査レポート
商品コード
1451561

臨床栄養市場レポート:製品、投与経路、用途、エンドユーザー、地域別、2024-2032

Clinical Nutrition Market Report by Product, Route of Administration, Application, End User, and Region 2024-2032

出版日: | 発行: IMARC | ページ情報: 英文 147 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.92円
臨床栄養市場レポート:製品、投与経路、用途、エンドユーザー、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臨床栄養市場規模は2023年に519億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて7.5%の成長率(CAGR)を示し、2032年までに1,010億米ドルに達すると予測しています。

臨床栄養学は、医療栄養療法を採用することで疾病管理に焦点を当てる栄養科学の専門分野を指します。また、必須栄養素の不足によって起こる慢性疾患に関連した栄養および代謝状態の診断と予防も含まれます。一般的に利用できる臨床栄養の種類には、乳児栄養、経腸栄養、非経口栄養などがあります。臨床栄養は、栄養不良の結果の軽減、疾患治療に対する反応の強化、免疫レベルの向上、摂取能力の強化など、数多くの利点を提供します。

臨床栄養市場の動向:

肥満、高血圧、異常なコレステロール値などのリスクを高める代謝障害の有病率の上昇が、主に世界の臨床栄養市場を牽引しています。さらに、慢性的な胃腸疾患にかかりやすい老年人口の拡大も、在宅医療モデルにおける臨床栄養の需要を促進しています。これに加えて、早産件数の増加と小児医療分野における臨床栄養のニーズの高まりが、市場の成長をさらに促進しています。さらに、ヘルスケアインフラの継続的なアップグレードと、疾病管理のための臨床栄養手順への容易なアクセスに関する政府の意識向上プログラムの導入が、重要な成長誘発要因として作用しています。これとは別に、COVID-19の大流行では、コロナウイルス感染のリスクを防ぐために、臨床栄養を含む免疫力を高める代替品に対する需要が大幅に増加しています。感染の結果、重度の食欲不振、無嗅覚性味覚障害、下痢などが生じ、病気に関連した栄養失調を引き起こす可能性があります。臨床栄養学は、COVID-19患者の免疫防御の改善とともに、急性栄養失調とタンパク質欠乏症の治療に役立ちます。さらに、脂質エマルションの最適化、液体形態の経口臨床栄養処方の導入など、臨床栄養ソリューションにおける重要な技術革新が、予測期間にわたって世界の臨床栄養市場を牽引すると期待されています。

本レポートで扱う主な質問

  • 2023年の世界の臨床栄養市場規模は?
  • 2024~2032年の世界の臨床栄養市場の予想成長率は?
  • 世界の臨床栄養市場を牽引する主要因は何か?
  • COVID-19が世界の臨床栄養市場に与えた影響は?
  • 臨床栄養の世界市場の製品別区分は?
  • 投与経路別臨床栄養の世界市場の内訳は?
  • 臨床栄養の世界市場におけるエンドユーザー別の区分は?
  • 臨床栄養の世界市場における主要地域は?
  • 臨床栄養の世界市場における主要プレイヤー/企業は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の臨床栄養市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:製品別

  • 乳児栄養
    • 市場動向
    • 市場予測
  • 非経口栄養
    • 市場動向
    • 市場予測
  • 経腸栄養
    • 市場動向
    • 市場予測

第7章 市場内訳:投与経路別

  • 経口
    • 市場動向
    • 市場予測
  • 経腸
    • 市場動向
    • 市場予測
  • 非経口
    • 市場動向
    • 市場予測

第8章 市場内訳:用途別

  • がん領域
    • 市場動向
    • 市場予測
  • 栄養不良
    • 市場動向
    • 市場予測
  • 代謝疾患
    • 市場動向
    • 市場予測
  • 消化器疾患
    • 市場動向
    • 市場予測
  • 神経疾患
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳:エンドユーザー別

  • 小児
    • 市場動向
    • 市場予測
  • 成人
    • 市場動向
    • 市場予測
  • 老人市場
    • 市場動向
    • 市場予測

第10章 市場内訳:地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • BASF SE
    • Baxter International Inc.
    • Danone S.A.
    • Fresenius SE & Co. KGaA
    • Grifols S.A.
    • Koninklijke DSM N.V.
    • Meiji Holdings Co. Ltd.
    • Nestle S.A.
    • Perrigo Company plc
    • Reckitt Benckiser Group PLC
図表

List of Figures

  • Figure 1: Global: Clinical Nutrition Market: Major Drivers and Challenges
  • Figure 2: Global: Clinical Nutrition Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Clinical Nutrition Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Clinical Nutrition Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Clinical Nutrition Market: Breakup by Route of Administration (in %), 2023
  • Figure 6: Global: Clinical Nutrition Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Clinical Nutrition Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Clinical Nutrition Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Clinical Nutrition (Infant Nutrition) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Clinical Nutrition (Infant Nutrition) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Clinical Nutrition (Parental Nutrition) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Clinical Nutrition (Parental Nutrition) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Clinical Nutrition (Enteral Nutrition) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Clinical Nutrition (Enteral Nutrition) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Clinical Nutrition (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Clinical Nutrition (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Clinical Nutrition (Enteral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Clinical Nutrition (Enteral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Clinical Nutrition (Parenteral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Clinical Nutrition (Parenteral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Clinical Nutrition (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Clinical Nutrition (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Clinical Nutrition (Malnutrition) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Clinical Nutrition (Malnutrition) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Clinical Nutrition (Metabolic Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Clinical Nutrition (Metabolic Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Clinical Nutrition (Gastrointestinal Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Clinical Nutrition (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Clinical Nutrition (Neurological Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Clinical Nutrition (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Clinical Nutrition (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Clinical Nutrition (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Clinical Nutrition (Pediatric) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Clinical Nutrition (Pediatric) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Clinical Nutrition (Adults) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Clinical Nutrition (Adults) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Clinical Nutrition (Geriatric) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Clinical Nutrition (Geriatric) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: North America: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: North America: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: United States: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: United States: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Canada: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Canada: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Asia-Pacific: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Asia-Pacific: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: China: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: China: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Japan: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Japan: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: India: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: India: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: South Korea: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: South Korea: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Australia: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Australia: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Indonesia: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Indonesia: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Europe: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Europe: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Germany: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Germany: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: France: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: France: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: United Kingdom: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: United Kingdom: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Italy: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Italy: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Spain: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Spain: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Russia: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Russia: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Latin America: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Latin America: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Brazil: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Brazil: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Mexico: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Mexico: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Others: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Others: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Middle East and Africa: Clinical Nutrition Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Middle East and Africa: Clinical Nutrition Market: Breakup by Country (in %), 2023
  • Figure 87: Middle East and Africa: Clinical Nutrition Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Global: Clinical Nutrition Industry: SWOT Analysis
  • Figure 89: Global: Clinical Nutrition Industry: Value Chain Analysis
  • Figure 90: Global: Clinical Nutrition Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Clinical Nutrition Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Clinical Nutrition Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Clinical Nutrition Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 4: Global: Clinical Nutrition Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Clinical Nutrition Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Clinical Nutrition Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Clinical Nutrition Market: Competitive Structure
  • Table 8: Global: Clinical Nutrition Market: Key Players
目次
Product Code: SR112024A5995

The global clinical nutrition market size reached US$ 51.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 101.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032.

Clinical nutrition refers to a specialized field of nutrition science that focuses on disease management by adopting medical nutrition therapies. It also includes the diagnosis and prevention of nutritional and metabolic conditions associated with chronic disorders that occur due to the lack of essential nutrients. Some of the commonly available types of clinical nutrition include infant nutrition, enteral nutrition, and parenteral nutrition. Clinical nutrition offers numerous benefits in reducing the consequences of malnutrition, enhancing the response to disease treatment, boosting immunity levels, enhancing ingestion abilities, etc.

Clinical Nutrition Market Trends:

The rising prevalence of metabolic disorders that increase the risk of obesity, high blood pressure, abnormal cholesterol levels, etc., is primarily driving the global clinical nutrition market. Moreover, the expanding geriatric population, who are more prone to chronic gastrointestinal ailments, is also propelling the demand for clinical nutrition in the home healthcare model. Besides this, elevating number of preterm births coupled with the inflating need for clinical nutrition in the pediatric medicine segment is further augmenting the market growth. Additionally, continuous upgradation of healthcare infrastructures and the introduction of government awareness programs regarding the easy accessibility to clinical nutrition procedures for disease management are acting as significant growth-inducing factors. Apart from this, in the COVID-19 pandemic, the demand for immunity-boosting alternatives, including clinical nutrition, has significantly increased to prevent the risk of coronavirus infection. The infection results in severe lack of appetite, anosmia dysgeusia, diarrhea, etc., which can lead to disease-related malnutrition. Clinical nutrition aid in treating acute malnutrition and protein deficiency along with improving immune defenses in COVID-19 patients. Moreover, significant innovations in clinical nutrition solutions, including lipid emulsions optimization, and the introduction of oral clinical nutrition formula in liquid form, are expected to drive the global clinical nutrition market over the forecasted period.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global clinical nutrition market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, route of administration, application and end user.

Breakup by Product:

Infant Nutrition

Parental Nutrition

Enteral Nutrition

Breakup by Route of Administration:

Oral

Enteral

Parenteral

Breakup by Application:

Cancer

Malnutrition

Metabolic Disorders

Gastrointestinal Disorders

Neurological Disorders

Others

Breakup by End User:

Pediatric

Adults

Geriatric

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, BASF SE, Baxter International Inc., Danone S.A., Fresenius SE & Co. KGaA, Grifols S.A., Koninklijke DSM N.V., Meiji Holdings Co. Ltd., Nestle S.A., Perrigo Company plc and Reckitt Benckiser Group PLC.

Key Questions Answered in This Report

  • 1. What was the size of the global clinical nutrition market in 2023?
  • 2. What is the expected growth rate of the global clinical nutrition market during 2024-2032?
  • 3. What are the key factors driving the global clinical nutrition market?
  • 4. What has been the impact of COVID-19 on the global clinical nutrition market?
  • 5. What is the breakup of the global clinical nutrition market based on the product?
  • 6. What is the breakup of the global clinical nutrition market based on the route of administration?
  • 7. What is the breakup of the global clinical nutrition market based on the end user?
  • 8. What are the key regions in the global clinical nutrition market?
  • 9. Who are the key players/companies in the global clinical nutrition market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Clinical Nutrition Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Infant Nutrition
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Parental Nutrition
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Enteral Nutrition
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Enteral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Parenteral
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Malnutrition
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Metabolic Disorders
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Gastrointestinal Disorders
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Neurological Disorders
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pediatric
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Adults
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Geriatric
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 B. Braun Melsungen AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 BASF SE
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Baxter International Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Danone S.A.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Fresenius SE & Co. KGaA
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Grifols S.A.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Koninklijke DSM N.V.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Meiji Holdings Co. Ltd.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Nestle S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Perrigo Company plc
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Reckitt Benckiser Group PLC
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis